Skip to main content
. Author manuscript; available in PMC: 2014 Jul 27.
Published in final edited form as: Amyloid. 2014 Jan 22;21(1):45–53. doi: 10.3109/13506129.2013.876400

Table 2.

* Biodistribution (%ID/g) of 125I-AEF in huIL6 mice with or without clodronate liposome treatment

15 min post injection
Spleen Liver
Clodronate + Control t-test Clodronate + Control t-test
8.3 ± 3.1 6.4 ± 0.6 p = 0.51 17.8 ± 3.5 19.5 ± 1.4 p = 0.48
4 h post injection
Spleen Liver
Clodronate + Control t-test Clodronate + Control t-test
18.1 ± 11.5 2.4 ± 0.5 p = 0.014 11.4 ± 2.9 6.3 ± 1.1 p = 0.006
*

huIL6 mice, either clodronate treated or controls (day −1), were injected with 125I AEF (see Figure 3) and at the designated times, animals (n=3/group for 15 min and N=5/group for 4 h) were euthanized and analyzed for % injected dose/gram of wet tissue of 125I content ± standard deviation.